• Abstract

    Elderly patients (EP) often have Chronic Sleep (CS). Although elders are among the categories with the highest need for therapy, these EP are often seen as challenging to treat. This study offers a thorough the studies on the therapy of persistent insomnia in EP with an emphasis on Evidence-Based (EB) therapeutic strategies. Meta-Analyses (MA), EB evaluations of therapy modalities, randomized controlled trials of Non-Pharmacologic (NP) treatment, and the features and treatment of insomnia were all criteria for selecting publications. MA, EB on solid, and studies including pertinent new data were given preference. When NP gets closer, the field is on their side. Among the medications used to treat insomnia include sedating antidepressants, barbiturates, OTC, prescription, and chloral hydrate antihistamines, as well as OTC and OTC nutritional supplements and cognitive behavioral therapy (CBT). SH drugs, including Benzodiazepine (BZD), Non-Benzodiazepine (NB), and melatonin agonists. NP therapies for insomnia in people of all ages have a large body of research supporting their efficacy and durability, yet still need to be addressed. With a few notable exceptions, the bulk of pharmacological trials found was of short length and did not just include EP as participants. The Non-benzodiazepine Sedative Hypnotics (NSH) proved to have minor, if any, substantial therapeutic benefits in effectiveness or tolerability in EP compared to BZD. Melatonin agonists are among the newer medicines with unique mechanisms of accomplishment and better security profiles that show promise for treating Chronic Insomnia (CI) in EP. There is no strong evidence base for the long-term use of sedative hypnotics (SH) to treat insomnia, and this practice has historically been discouraged because of concerns about possible adverse effects such as cognitive impairment, daytime sedation, motor incoordination, and an increased risk of falls and car accidents. The most effective management technique for senior people with CI will need more study to establish the extended-term consequences of therapy.

  • References

    1. Basheti, M. M., Tran, M., Wong, K., Gordon, C., Grunstein, R., & Saini, B. (2022). Australian Consultant Pharmacists’ Potential Roles in Sleep Health Care: Exploring a New Avenue for Improving the Management of Insomnia. Behavioral Sleep Medicine, 20(5), 622-637. https://doi.org/10.1080/15402002.2021.1975718
    2. Brietzke, E., Vazquez, G. H., Kang, M. J., & Soares, C. N. (2019). Pharmacological treatment for insomnia in patients with major depressive disorder. Expert Opinion on Pharmacotherapy, 20(11), 1341-1349. https://doi.org/10.1080/14656566.2019.1614562
    3. Chan, N. Y., Chan, J. W. Y., Li, S. X., & Wing, Y. K. (2021). Non-pharmacological approaches for the management of insomnia. Neurotherapeutics, 18(1), 32-43. https://doi.org/10.1007/s13311-021-01029-2
    4. Choi, H., Youn, S., Um, Y. H., Kim, T. W., Ju, G., Lee, H. J., & Chung, S. (2020). Korean clinical practice guideline for the diagnosis and treatment of insomnia in adults. Psychiatry investigation, 17(11), 1048. https://doi.org/10.30773%2Fpi.2020.0146
    5. Chung, K., Kim, S., Lee, E., & Park, J. Y. (2020). Mobile app use for insomnia self-management in urban community-dwelling older Korean adults: retrospective intervention study. JMIR mHealth and uHealth, 8(8), e17755. https://doi.org/10.2196/17755
    6. D’Aurea, C. V. R., Frange, C., Poyares, D., Souza, A. A. L. D., & Lenza, M. (2022). Physical exercise as a therapeutic approach for adults with insomnia: systematic review and meta-analysis. einstein (São Paulo), 20. https://doi.org/10.31744/einstein_journal/2022AO8058
    7. Gebara, M. A., DiNapoli, E. A., Lederer, L. G., Bramoweth, A. D., Germain, A., Kasckow, J. W., & Karp, J. F. (2019). Brief behavioral treatment for insomnia in older adults with late-life treatment-resistant depression and insomnia: a pilot study. Sleep and biological rhythms, 17, 287-295. https://doi.org/10.1007/s41105-019-00211-6
    8. Koffel, E., & Hagedorn, H. (2020). Provider perspectives of implementation of an evidence-based insomnia treatment in Veterans Affairs (VA) primary care: barriers, existing strategies, and future directions. Implementation Science Communications, 1, 1-10. https://doi.org/10.1186/s43058-020-00096-4
    9. Krystal, A. D., Prather, A. A., & Ashbrook, L. H. (2019). The assessment and management of insomnia: an update. World Psychiatry, 18(3), 337-352. https://doi.org/10.1002/wps.20674
    10. Kwak, A., Jacobs, J., Haggett, D., Jimenez, R., & Peppercorn, J. (2020). Evaluation and management of insomnia in women with breast cancer. Breast cancer research and treatment, 181, 269-277. https://doi.org/10.1007/s10549-020-05635-0
    11. Kwon, C. Y., Lee, B., Cheong, M. J., Kim, T. H., Jang, B. H., Chung, S. Y., & Kim, J. W. (2021). Non-pharmacological treatment for elderly individuals with insomnia: a systematic review and network meta-analysis. Frontiers in psychiatry, 11, 608896. https://doi.org/10.3389/fpsyt.2020.608896
    12. Marbin, A., Brooke, M., Thomas, B., Martinez, B. M., Blum, B., & Neuhut, S. (2023). ZaleplonVersusZolpidem Use in Older Adults Being Treated for Insomnia: A Review. The American Journal of Geriatric Psychiatry, 31(3), S68-S69. https://doi.org/10.1016/j.jagp.2022.12.229
    13. McCrae, C. S., Curtis, A. F., Williams, J. M., Dautovich, N. D., McNamara, J. P., Stripling, A., & Marsiske, M. (2020). Effects of brief behavioral treatment for insomnia on daily associations between self-reported sleep and objective cognitive performance in older adults. Behavioral sleep medicine, 18(5), 577-588.https://doi.org/10.1080/15402002.2019.1632201
    14. McLaren, D. M., Evans, J., Baylan, S., Smith, S., & Gardani, M. (2023). The effectiveness of the behavioral components of cognitive behavioral therapy for insomnia in older adults: A systematic review. Journal of sleep research, e13843. https://doi.org/10.1111/jsr.13843
    15. Olatunde, K., & Patton, S. (2023). Association Between Insomnia and Healthcare Utilization: A Scoping Review of the Literature. American Journal of Lifestyle Medicine, 15598276231164953. https://doi.org/10.1177/15598276231164953
    16. Palagini, L., Manni, R., Aguglia, E., Amore, M., Brugnoli, R., Girardi, P., ...&Biggio, G. (2020). Expert opinions and consensus recommendations for the evaluation and management of insomnia in clinical practice: joint statements of five Italian scientific societies. Frontiers in Psychiatry, 11, 558. https://doi.org/10.3389/fpsyt.2020.00558
    17. Roach, M., Juday, T., Tuly, R., Chou, J. W., Jena, A. B., &Doghramji, P. P. (2021). Challenges and opportunities in insomnia disorder. International Journal of Neuroscience, 131(11), 1058-1065. https://doi.org/10.1080/00207454.2020.1773460
    18. Rosenberg, R. P., Benca, R., Doghramji, P., & Roth, T. (2023). A 2023 update on managing insomnia in primary care: Insights from an expert consensus group. The Primary Care Companion for CNS Disorders, 25(1), 45169. https://doi.org/10.4088/PCC.22nr03385
    19. Sadler, P., McLaren, S., Klein, B., & Jenkins, M. (2020). Cognitive behavior therapy for insomnia and depression: qualitative reflections from older adults who participated in a randomized controlled trial. Aging & Mental Health, 24(6), 932-938. https://doi.org/10.1080/13607863.2019.1571013
    20. Salvemini, A., D’Onofrio, G., Ciccone, F., Greco, A., Tullio, A., Addante, F., ...& Greco, A. (2019). Insomnia and information and communication technologies (ICT) in elderly people: a systematic review. Medical sciences, 7(6), 70. https://doi.org/10.3390/medsci7060070
    21. Suen, L. K., Molassiotis, A., Yueng, S. K. W., & Yeh, C. H. (2019). Comparison of magnetic auriculotherapy, laser auriculotherapy and their combination for the treatment of insomnia in the elderly: a double-blinded randomized trial. Evidence-Based Complementary and Alternative Medicine, 2019. https://doi.org/10.1155/2019/3651268
    22. Sweetman, A., Knieriemen, A., Hoon, E., Frank, O., Stocks, N., Natsky, A., ...& McEvoy, R. D. (2021). Implementation of a digital cognitive behavioral therapy for insomnia pathway in primary care. Contemporary Clinical Trials, 107, 106484. https://doi.org/10.1016/j.cct.2021.106484
    23. Tanaka, M., Kusaga, M., Nyamathi, A. M., & Tanaka, K. (2019). Effects of brief cognitive behavioral therapy for insomnia on improving depression among community‐dwelling older adults: A randomized controlled comparative study. Worldviews on Evidence‐Based Nursing, 16(1), 78-86. https://doi.org/10.1111/wvn.12342
    24. Wallace, D. M., Wohlgemuth, W. K., Trotti, L. M., Amara, A. W., Malaty, I. A., Factor, S. A., ... & Hauser, R. A. (2020). Practical evaluation and management of insomnia in Parkinson's disease: a review. Movement disorders clinical practice, 7(3), 250-266. https://doi.org/10.1002/mdc3.12899
    25. Wilson, S., Anderson, K., Baldwin, D., Dijk, D. J., Espie, A., Espie, C., ...& Sharpley, A. (2019). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias, and circadian rhythm disorders: an update. Journal of Psychopharmacology, 33(8), 923-947. https://doi.org/10.1177/0269881119855343s

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2023 Malque Publishing

How to cite

Singh, R., Pallavi, Arun, J. K., Kulshrestha, S., & Gupta, M. (2024). Managing insomnia in Elderly patients: Evidence-based treatment approaches. Multidisciplinary Reviews, 6, 2023ss049. https://doi.org/10.31893/multirev.2023ss049
  • Article viewed - 115
  • PDF downloaded - 37